Successful treatment of neutropenia in the hyper-immunoglobulin M syndrome with granulocyte colony-stimulating factor.

Authors:
  • JCJ Cordoba
    J Cordoba
  • AIA J Infante
    A J Infante
  • MCM E Conley
    M E Conley

  • 1 May 1994
    • journal article
    • case report
    • Vol. 16  (2) , 160-3
    • PMID:7513136
Abstract
A young boy with hyper-immunoglobulin M (IgM) syndrome had recurrent severe infections, failure to thrive, and chronic neutropenia for 2 years despite treatment with i.v. gammaglobulin (IVIG). With the addition of granulocyte colony-stimulating factor (G-CSF; Filgrastim, Amgen, Inc., Thousand Oaks, CA), increased doses of IVIG, and prophylactic trimethoprim-sulfamethoxazole, his absolute neutrophil count increased from 0.64 x 10(9)/L to 3.36 x 10(9)/L, and he has been free of significant infection for the past 22 months. The use of G-CSF merits consideration in patients with hyper-IgM syndrome and severe neutropenia.